Table 4 reports the prevalence of BRCA1 and BRCA2 variants of 8.1% among African American and Black women with breast cancer is high and clinically important to recognize, especially in the setting of historic obstacles to achieving appropriate rates of testing in this group. The gene discussed is BRCA1; the disease is breast cancer.